array:22 [ "pii" => "S1578219011707983" "issn" => "15782190" "doi" => "10.1016/S1578-2190(11)70798-3" "estado" => "S300" "fechaPublicacion" => "2011-05-01" "aid" => "70798" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "copyrightAnyo" => "2011" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2011;102:241-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2198 "formatos" => array:3 [ "EPUB" => 35 "HTML" => 1398 "PDF" => 765 ] ] "itemSiguiente" => array:18 [ "pii" => "S1578219011707995" "issn" => "15782190" "doi" => "10.1016/S1578-2190(11)70799-5" "estado" => "S300" "fechaPublicacion" => "2011-05-01" "aid" => "70799" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "rev" "cita" => "Actas Dermosifiliogr. 2011;102:244-54" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2301 "formatos" => array:3 [ "EPUB" => 34 "HTML" => 1517 "PDF" => 750 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Portfolios: A Tool for the Training and Assessment of Residents in Dermatology, Part 1" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "244" "paginaFinal" => "254" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El portafolio como herramienta de formación y evaluación de los residentes de Dermatología (I)" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.M. Casanova, X. Soria, L. Borrego, D. de Argila, M. Ribera, R. Pujol" "autores" => array:6 [ 0 => array:2 [ "nombre" => "J.M." "apellidos" => "Casanova" ] 1 => array:2 [ "nombre" => "X." "apellidos" => "Soria" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Borrego" ] 3 => array:2 [ "nombre" => "D." "apellidos" => "de Argila" ] 4 => array:2 [ "nombre" => "M." "apellidos" => "Ribera" ] 5 => array:2 [ "nombre" => "R." "apellidos" => "Pujol" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011707995?idApp=UINPBA000044" "url" => "/15782190/0000010200000004/v1_201304241543/S1578219011707995/v1_201304241543/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Opinion article</span>" "titulo" => "Intermittent Treatment Regimens and the Rational (Efficient) Use of Biologic Agents in Psoriasis" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "241" "paginaFinal" => "243" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "D. Moreno-Ramírez" "autores" => array:1 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Moreno-Ramírez" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Unidad de Gestión Clínica de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, Spain" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Uso racional (eficiente) de biológicos y terapia intermitente en psoriasis" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2011-01-13" "fechaAceptado" => "2011-02-09" "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Rational Use of Drugs" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "World Health Organization" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:4 [ "titulo" => "Report of the Conference of Experts" "fecha" => "1985" "editorial" => "WHO" "editorialLocalizacion" => "Geneva" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ley 29/2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios. BOE número 178, 27 de julio de 2006." ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Inforcoan. Sistema de Contabilidad Analítica de Hospitales y Distritos. Servicio Andaluz de Salud. Seville: Consejería de Salud, Junta de Andalucía; 2009." ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of weight on the efficacy of biologic therapy in patients with psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L. Clark" 1 => "M. Lebwohl" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2007.11.011" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2008" "volumen" => "58" "paginaInicial" => "443" "paginaFinal" => "446" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18083274" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Papp" 1 => "J. Crowley" 2 => "J.P. Ortonne" 3 => "J. Leu" 4 => "M. Okun" 5 => "S.R. Gupta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2010.10139.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2011" "volumen" => "164" "paginaInicial" => "434" "paginaFinal" => "441" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21083543" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treating psoriasis with etanercept in Italian clinical practice. Prescribing practices and duration of remission following discontinuation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Arcese" 1 => "N. Aste" 2 => "Bettacchini" 3 => "Camplone" 4 => "F. Cantoresi" 5 => "M. Caproni" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Drug Invest" "fecha" => "2010" "volumen" => "30" "paginaInicial" => "507" "paginaFinal" => "516" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficiency of biologic agents in the treatment of moderate to severe psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.J. Blasco" 1 => "P. Lázaro" 2 => "C. Ferrándiz" 3 => "A. García-Díez" 4 => "J. Liso" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2009" "volumen" => "100" "paginaInicial" => "792" "paginaFinal" => "803" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19889301" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Economic evaluation of etanercept in the management of chronic plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Lloyd" 1 => "P. Reeves" 2 => "P. Conway" 3 => "A. Reynolds" 4 => "G. Baxter" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2008.08863.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2009" "volumen" => "160" "paginaInicial" => "380" "paginaFinal" => "386" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18808413" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010200000004/v1_201304241543/S1578219011707983/v1_201304241543/en/main.assets" "Apartado" => array:4 [ "identificador" => "6152" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Opinion Article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010200000004/v1_201304241543/S1578219011707983/v1_201304241543/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219011707983?idApp=UINPBA000044" ]
Información de la revista
Vol. 102. Núm. 4.
Páginas 241-243 (mayo 2011)
Vol. 102. Núm. 4.
Páginas 241-243 (mayo 2011)
Opinion article
Acceso a texto completo
Intermittent Treatment Regimens and the Rational (Efficient) Use of Biologic Agents in Psoriasis
Uso racional (eficiente) de biológicos y terapia intermitente en psoriasis
Visitas
5306
D. Moreno-Ramírez
Unidad de Gestión Clínica de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, Spain
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
World Health Organization.
The Rational Use of Drugs.
Report of the Conference of Experts, WHO, (1985),
[2.]
Ley 29/2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios. BOE número 178, 27 de julio de 2006.
[3.]
Inforcoan. Sistema de Contabilidad Analítica de Hospitales y Distritos. Servicio Andaluz de Salud. Seville: Consejería de Salud, Junta de Andalucía; 2009.
[4.]
L. Clark, M. Lebwohl.
The effect of weight on the efficacy of biologic therapy in patients with psoriasis.
J Am Acad Dermatol, 58 (2008), pp. 443-446
[5.]
K. Papp, J. Crowley, J.P. Ortonne, J. Leu, M. Okun, S.R. Gupta, et al.
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy.
Br J Dermatol, 164 (2011), pp. 434-441
[6.]
A. Arcese, N. Aste, Bettacchini, Camplone, F. Cantoresi, M. Caproni, et al.
Treating psoriasis with etanercept in Italian clinical practice. Prescribing practices and duration of remission following discontinuation.
Clin Drug Invest, 30 (2010), pp. 507-516
[7.]
A.J. Blasco, P. Lázaro, C. Ferrándiz, A. García-Díez, J. Liso.
Efficiency of biologic agents in the treatment of moderate to severe psoriasis.
Actas Dermosifiliogr, 100 (2009), pp. 792-803
[8.]
A. Lloyd, P. Reeves, P. Conway, A. Reynolds, G. Baxter.
Economic evaluation of etanercept in the management of chronic plaque psoriasis.
Br J Dermatol, 160 (2009), pp. 380-386
Copyright © 2011. Academia Española de Dermatología y Venereología and Elsevier España, S.L.